Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream

Experimental Hematology

Volumn 30, Issue 6, 2002, Pages 503-512

  Ginzinger, David G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; REAGENT;

ACCURACY; ALLELE; ANALYTIC METHOD; ARTICLE; DNA DETERMINATION; GENE EXPRESSION; GENETIC ANALYSIS; INSTRUMENTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA ANALYSIS; TRANSGENE; VIRUS TITRATION;

BIOTECHNOLOGY; GENE EXPRESSION REGULATION; HEMATOLOGY; HUMANS; LEUKEMIA; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0036278859     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00806-8     Document Type: Article

References (65)

1. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
2. A novel method for real time quantitative RT-PCR
3. Real-time quantitative PCR
4. Molecular beacons: Probes that fluoresce upon hybridization
5. Real-time reverse-transcriptase polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I
6. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods
7. Comparison between Taq DNA polymerase and its Stoffel fragment for quantitative real-time PCR with hybridization probes
8. A closed tube format for amplification and detection of DNA based on energy transfer
9. 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures
10. Rapid detection of the 22q11.2 deletion with quantitative real-time PCR
11. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative PCR assay
12. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis
13. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay
14. Quantitative real-time PCR assay for determining transgene copy number in transformed plants
15. Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis
16. An improved real time PCR method for simultaneous detection of C282Y and H63D mutations in the HFE gene associated with hereditary hemochromatosis
17. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus
18. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis
19. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction
20. Quiescent angiogenesis in transgenic mice expressing constitutively active hypoxia-inducible factor-1a
21. Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR
22. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue
23. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction
24. Global cDNA amplification combined with real-time RT-PCR: Accurate quantification of multiple human potassium channel genes at the single cell level
25. Higher LPS-stimulated TNF-α mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients
26. A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients
27. The involvement of human-nuc gene in polyploidization of K562 cell line
28. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation
29. Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay
30. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia
31. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
32. The AML1/MTG8 fusion transcript in t(8;21) positive AML and its implication for the detection of minimal residual disease; Malignancy
33. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
34. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a "real time" quantitative RT-PCR assay
35. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome-positive chronic myeloid leukemia correlates with the disease stage
36. Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α-treated chronic myeloid leukemia
37. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes
38. + childhood ALL by real-time reverse transcription polymerase chain reaction
39. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia
40. Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma
41. Real-time 5′ > 3′ exonuclease-based PCR assay for detection of the t(11;14)(q13;q32)
42. + cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors
43. Frequency of the bcl-2/IgH rearrangement in normal individuals: Implications for the monitoring of disease in patients with follicular lymphoma
44. Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance
45. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer
46. Quantification of murine cytokine mRNAs using real-time quantitative reverse-transcriptase PCR
47. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: Validation of a new real-time RT-PCR technology
48. Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations
49. Absolute quantification of mRNA using REAL-TIME reverse transcription polymerase chain reaction assays
50. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR
51. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
52. Quantitative molecular analysis of laser-microdissected paraffin-embedded human tissues
53. Quantitative amplification of genomic DNA from histological tissue sections after staining with nuclear dyes and laser capture microdissection
54. Real-time quantitative RT-PCR after laser-assisted cell picking
55. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction
56. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes
57. Detection of minimal residual disease
58. Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
59. A quantitative, internally controlled real-time PCR assay for the detection of parvovirus B19 DNA
60. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture
61. Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing
62. Development of a model system to compare cell separation methods for the isolation of fetal cells from maternal blood
63. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
64. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21
65. Plasma DNA as a prognostic marker in trauma patients